Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,871 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study.
Zhang X, Xu N, Yang Y, Lin H, Liu B, Du X, Liu X, Liang R, Chen C, Huang J, Zhu H, Pan L, Wang X, Li G, Liu Z, Zhang Y, Liu Z, Hu J, Liu C, Li F, Yang W, Meng L, Han Y, Lin L, Zhao Z, Tu C, Zheng C, Bai Y, Zhou Z, Chen S, Qiu H, Yang L, Sun X, Sun H, Zhou L, Liu Z, Wang D, Guo J, Pang L, Zeng Q, Suo X, Zhang W, Zheng Y, Zhang Y, Li W, Jiang Q. Zhang X, et al. Among authors: jiang q. Clin Lymphoma Myeloma Leuk. 2024 Jun;24(6):e257-e266. doi: 10.1016/j.clml.2024.02.008. Epub 2024 Feb 15. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38461040
Cytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapy.
Zhu HH, Jiang H, Jiang B, Lu J, Jiang Q, Bao L, Zhang XH, Qin YZ, Huang XJ. Zhu HH, et al. Among authors: jiang b, jiang q, jiang h. Leuk Lymphoma. 2013 Nov;54(11):2452-7. doi: 10.3109/10428194.2013.776679. Epub 2013 Apr 2. Leuk Lymphoma. 2013. PMID: 23432721
Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?
Qin YZ, Jiang Q, Jiang H, Li JL, Li LD, Zhu HH, Lai YY, Lu XJ, Liu YR, Jiang B, Huang XJ. Qin YZ, et al. Among authors: jiang b, jiang q, jiang h. Leuk Res. 2013 Sep;37(9):1035-40. doi: 10.1016/j.leukres.2013.06.003. Epub 2013 Jun 26. Leuk Res. 2013. PMID: 23810191
Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy.
Qin YZ, Xu LP, Chen H, Jiang Q, Wang Y, Jiang H, Zhang XH, Han W, Chen YH, Wang FR, Wang JZ, Zhu HH, Liu YR, Jiang B, Liu KY, Huang XJ. Qin YZ, et al. Among authors: jiang b, jiang q, jiang h. Leuk Lymphoma. 2015;56(11):3116-23. doi: 10.3109/10428194.2015.1032964. Epub 2015 May 12. Leuk Lymphoma. 2015. PMID: 25804769
[A prospective, multi-centre clinical trial to evaluate the early clinical efficacy and safety of a generic imatinib in treating patients with chronic phase of chronic myelogenous leukemia].
Jiang Q, Zhao D, Jin J, Wu D, Meng F, Hu J, Liu B, DU X, Liu T, Li Y, Hou M, Han X, Shen Z, Ma J. Jiang Q, et al. Zhonghua Xue Ye Xue Za Zhi. 2015 Aug;36(8):651-5. doi: 10.3760/cma.j.issn.0253-2727.2015.08.005. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26462633 Free PMC article. Clinical Trial. Chinese.
Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients.
Qin YZ, Jiang Q, Jiang H, Lai YY, Zhu HH, Liu YR, Jiang B, Huang XJ. Qin YZ, et al. Among authors: jiang b, jiang q, jiang h. Medicine (Baltimore). 2016 Jan;95(2):e2486. doi: 10.1097/MD.0000000000002486. Medicine (Baltimore). 2016. PMID: 26765457 Free PMC article.
8,871 results